Singlomics (Beijing DanXu) Biopharmaceuticals
PrivateLast Round
Strategic
Aug 2, 2022
Total Funding Raised
$61.9M
Company Overview
Singlomics (Beijing DanXu) Biopharmaceuticals operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Strategic round in August 2022.
Singlomics (Beijing DanXu) Biopharmaceuticals is a biopharmaceutical company that discovers and develops antibody therapeutics for oncology, inflammation, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singlomics (Beijing DanXu) Biopharmaceuticals Comparables
Compare Singlomics (Beijing DanXu) Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Sungen Biomedical Technology Co., Ltd. | 82% | |
| AbCellera | 80% | |
| HiFiBiO | 79% |
For institutional investors. Book with your work email.
Singlomics (Beijing DanXu) Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 2, 2022 | ||||
| Series B | Feb 12, 2022 | ||||
| Series A | Sep 4, 2020 |
For institutional investors. Book with your work email.
Singlomics (Beijing DanXu) Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | Strategic |
| Beijing Chang Development | Series A |
| Hillhouse Investment | Series B |
| Guoke Jiahe Capital | Series B |
| Hosen Capital | Series B |
| 健壹资本 | Series B, Strategic |
| Legend Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2022
Tencent Exploration and others participated in the strategic round.
- Feb 12, 2022
$47.3M round led by Hosen Capital and Legend Capital.
For institutional investors. Book with your work email.
Singlomics (Beijing DanXu) Biopharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Singlomics (Beijing DanXu) Biopharmaceuticals's valuation, stock price, and market status.
Is Singlomics (Beijing DanXu) Biopharmaceuticals a public or private company?
Singlomics (Beijing DanXu) Biopharmaceuticals is a private company.
What is the current stock price of Singlomics (Beijing DanXu) Biopharmaceuticals?
Singlomics (Beijing DanXu) Biopharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Singlomics (Beijing DanXu) Biopharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Singlomics (Beijing DanXu) Biopharmaceuticals worth (valuation)?
Valuation information for Singlomics (Beijing DanXu) Biopharmaceuticals is not publicly available.
Can I buy Singlomics (Beijing DanXu) Biopharmaceuticals stock?
Singlomics (Beijing DanXu) Biopharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Singlomics (Beijing DanXu) Biopharmaceuticals's last funding round?
Singlomics (Beijing DanXu) Biopharmaceuticals's most recent funding round was Strategic on August 2, 2022.
Who are the main investors in Singlomics (Beijing DanXu) Biopharmaceuticals?
Key investors in Singlomics (Beijing DanXu) Biopharmaceuticals include Hosen Capital, Legend Capital, Huagai Capital.
Will Singlomics (Beijing DanXu) Biopharmaceuticals IPO soon?
No public IPO plans have been announced for Singlomics (Beijing DanXu) Biopharmaceuticals.
How can I track Singlomics (Beijing DanXu) Biopharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Singlomics (Beijing DanXu) Biopharmaceuticals's shares on secondary markets.